![](/img/cover-not-exists.png)
TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis
DJ Burge, C Shu, RW Martin, TW Littlejohn, DJ Wallace…Volume:
9
Language:
english
DOI:
10.1186/ar2258
Date:
October, 2007
File:
PDF, 148 KB
english, 2007